Study S000220

A Randomized, Single-blind, Controlled, Parallel Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes

ClinicalTrials.gov record

Registration

Registration: NCT07195994
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: RECRUITING
Enrollment: 90
Start: 2026-02-05
Primary completion: 2026-09
Lead sponsor: QuickSilver Scientific
Conditions: Prediabetes / Type 2 Diabetes
Interventions: DIETARY_SUPPLEMENT:AMPK Charge+®; DIETARY_SUPPLEMENT:AMPK Charge+® with semaglutide
Results posted: FALSE

Registered primary outcomes

The difference in change in fasting blood glucose between AMPK Charge+® and AMPK Charge+® with semaglutide [Day 0 to 84]
The difference in change in fasting insulin between AMPK Charge+® and AMPK Charge+® with semaglutide [Day 0 to 84]
The difference in change in hemoglobin A1c (HbA1c) between AMPK Charge+® and AMPK Charge+® with semaglutide [Day 0 to 84]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.